These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24638120)

  • 1. Profiting and providing less care: comprehensive services at for-profit, nonprofit, and public opioid treatment programs in the United States.
    Bachhuber MA; Southern WN; Cunningham CO
    Med Care; 2014 May; 52(5):428-34. PubMed ID: 24638120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ownership differences in the provision of outpatient substance abuse services.
    Burke AC; Rafferty JA
    Adm Soc Work; 1994; 18(3):59-91. PubMed ID: 10138940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The quasi-market for adult residential care in the UK: Do for-profit, not-for-profit or public sector residential care and nursing homes provide better quality care?
    Barron DN; West E
    Soc Sci Med; 2017 Apr; 179():137-146. PubMed ID: 28273611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two separate tracks? A national multivariate analysis of differences between public and private substance abuse treatment programs.
    Rodgers JH; Barnett PG
    Am J Drug Alcohol Abuse; 2000 Aug; 26(3):429-42. PubMed ID: 10976667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment for substance abuse in Australia: a comparison of public and private programs.
    McNeese-Smith DK
    Int J Psychiatr Nurs Res; 2003 Sep; 9(1):1025-38. PubMed ID: 14533233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multitasking in Nursing Homes: Differences Between For-Profit and Nonprofit Quality Outcomes.
    Gaudet Hefele J; Wang XJ; Bishop CE; Barooah A
    Gerontologist; 2019 Nov; 59(6):1034-1043. PubMed ID: 30428053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlates of specialty substance use treatment among adults with opioid use disorders.
    Romo E; Ulbricht CM; Clark RE; Lapane KL
    Addict Behav; 2018 Nov; 86():96-103. PubMed ID: 29551551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meeting the change challenge: managing growth in the nonprofit and public human services sectors.
    Edwards RL; Eadie DC
    Adm Soc Work; 1994; 18(2):107-23. PubMed ID: 10138340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficiency and productivity changes in large urban hospitals 1994-2002: ownership, markets, and the uninsured.
    Ferrier GD; Valdmanis VG
    Adv Health Econ Health Serv Res; 2008; 18():157-76. PubMed ID: 19725361
    [No Abstract]   [Full Text] [Related]  

  • 10. Unforeseen consequences: Medicaid and the funding of nonprofit service organizations.
    Allard SW; Smith SR
    J Health Polit Policy Law; 2014 Dec; 39(6):1135-72. PubMed ID: 25248960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimensions of publicness and performance in substance abuse treatment organizations.
    Heinrich CJ; Fournier E
    J Policy Anal Manage; 2004; 23(1):49-70. PubMed ID: 14976993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doing "good" vs. doing "well": the role of nonprofits in society.
    Berman HJ
    Inquiry; 2002; 39(1):5-11. PubMed ID: 12067075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suicide Prevention Programs Across U.S. Outpatient Mental Health Care Settings: Differences by Facility Ownership.
    Hung P; Shih YW; Brown MJ; Crouch E
    Psychiatr Serv; 2021 Sep; 72(9):998-1005. PubMed ID: 33657840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in adult day services center characteristics by center ownership: United States, 2012.
    Dwyer LL; Harris-Kojetin LD; Valverde RH
    NCHS Data Brief; 2014 Sep; (165):1-8. PubMed ID: 25207830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of the availability of hepatitis C testing services in opioid treatment programs: results from a national study.
    Frimpong JA; D'Aunno T; Jiang L
    Am J Public Health; 2014 Jun; 104(6):e75-82. PubMed ID: 24825236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of viral hepatitis services into opioid treatment programs.
    Kresina TF; Bruce RD; Lubran R; Clark HW
    J Opioid Manag; 2008; 4(6):369-81. PubMed ID: 19192765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance Use Disorder Program Availability in Safety-Net and Non-Safety-Net Hospitals in the US.
    Chang JE; Franz B; Pagán JA; Lindenfeld Z; Cronin CE
    JAMA Netw Open; 2023 Aug; 6(8):e2331243. PubMed ID: 37639270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicaid Expansion and Availability of Opioid Medications in the Specialty Substance Use Disorder Treatment System.
    Abraham AJ; Yarbrough CR; Harris SJ; Adams GB; Andrews CM
    Psychiatr Serv; 2021 Feb; 72(2):148-155. PubMed ID: 33267651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Access to treatment-related and support services in methadone treatment programs.
    Berkman ND; Wechsberg WM
    J Subst Abuse Treat; 2007 Jan; 32(1):97-104. PubMed ID: 17175403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What Strategies Are Hospitals Adopting to Address the Opioid Epidemic? Evidence From a National Sample of Nonprofit Hospitals.
    Franz B; Cronin CE; Pagan JA
    Public Health Rep; 2021; 136(2):228-238. PubMed ID: 33176117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.